Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Abstract Background The study compared biologic (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs) efficacy and safety in elderly rheumatoid arthritis (RA) patients over a period of 1 year. Results This retrospective study included 52 RA patients. At baseline elderly pati...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yasemin Tombak, Ajda Bal, Emel Eksioglu, Nihan Abidin, Ozgur Zeliha Karaahmet, Deniz Dulgeroglu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	SpringerOpen 2025-06-01
Sarja:	Egyptian Rheumatology and Rehabilitation
Aiheet:	bDMARDs Elderly EULAR HAQ Rheumatoid arthritis Safety of DMARDs
Linkit:	https://doi.org/10.1186/s43166-025-00336-2
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!